Hipertensión arterial pulmonar asociada a cortocircuitos pretricuspídeos: perfil de riesgo y supervivencia #REC #AheadOfPrint Francisco Buendía Luis María Andrés Lalaguna Luis Martinez Dolz @RuedaXimo revespcardiol.org//es-hipertensi…

Check out👀our latest analysis in JAHA Clinical Significance of Exercise Pulmonary Hypertension With a Negative Diastolic Stress Test for Suspected Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association (ahajournals.org) 1/🧵

ERJ: In pulmonary arterial hypertension, differences in cardiac output augmentation during exercise are highly dependent on afterload, right ventricular stiffness and interventricular interactions bit.ly/3WWPQnV

📰 The role of nursing in right heart catheterization Advantages from peripheral venous access ✏️ Original by J Gonzalez-Vela Journal of Healthcare Quality Research #RevistaSECA #JHQR 👉 bit.ly/4daSpb1 ✅ #QualityHealthcare #Cardiaccatheterization #Cardiovascularnursing #Pulmonaryhypertension

Want to dive deep into anticoagulants and #PAH and #CTEPH? Don’t miss this must-read article published in Blood Reviews by the Saint-Etienne team. Proud to have contributed to this work! Pulmotension Société de Pneumologie de Langue Française (SPLF) InsermU999 Laurent Bertoletti sciencedirect.com/science/articl…

Congrats to Athénaïs Boucly Olivier Sitbon and Pulmotension network for this important article "Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with #PAH" InsermU999 Société de Pneumologie de Langue Française (SPLF) erj.ersjournals.com/content/64/3/2…

Post PE Phenotypes Described by Invasive CPET 3 profiles : Cluster 1- ⬆️ RV afterload and impaired ventilatory efficiency. Cluster 2- ⬆️ RV afterload with ⬇️ in respiratory mechanics. Cluster 3-mild derangement in RV afterload with mild ⬇️in peak CO journal.chestnet.org/article/S0012-…

🔥Just published under #EHJCVI 🔥 ✅ Principles of Exercise-Induced Pulmonary Hypertension ✅ Association with latest guidelines ✅ Practical guide for applying the mPAP/CO slope in clinical practice Philippe B. Bertrand Sebastiaan Dhont ➡️ academic.oup.com/ehjcimaging/ad… Bernhard Gerber Julia Grapsa MD, PhD

Pulmonary hypertension (PH) due to left heart disease is the most prevalent cause of PH. It's complex to diagnose & manage, often underdiagnosed in older adults. Accurate testing & early detection are key to better outcomes. More: bit.ly/3XMFeYJ #JACCHF #cvPAH

After the French DELPHI-2 study, thank you to our Dutch colleagues for involving us in this new step with the DOLPHIN-GENESIS study on screening for PAH in unaffected BMPR2 carriers. Harm Jan Bogaard Amsterdam UMC Pulmotension InsermU999 erj.ersjournals.com/content/64/4/2…

The "DELPHI-2 Study" journey continue with our latest publication in Chest: "Role of Exercise Hemodynamics in the Prediction of #PAH in BMPR2 Mutation Carriers" Pulmotension Société de Pneumologie de Langue Française (SPLF) InsermU999 HTaPFrance Christian Gerges Harm Jan Bogaard journal.chestnet.org/article/S0012-…

🚨El tercer capítulo del número especial de #reccardioclinics nos trae una interesantísima revisión🫀🩺 “Abordaje de la hipertensión arterial pulmonar para el clínico: fisiopatología, diagnóstico y tratamiento” Manuel Giráldez Mercedes Rivas-Lasarte @AlvarezBarredo Irene Martín de Miguel ⬇️

ERJ: The inhaled soluble guanylate cyclase stimulator MK-5475 reduced PVR and was well tolerated in patients with PAH, without evidence of systemic side-effects such as hypotension, suggesting a pulmonary selective pharmacodynamic effect bit.ly/4dJ2nAs

Comorbidities reduce survival and quality of life (QoL) in emphysema patients with severe hyperinflation. Appropriate treatment of anxiety, low body mass index and pulmonary arterial hypertension could lead to a survival benefit and improvement in QoL. bit.ly/4aWcK26

Hipertensión pulmonar tromboembólica crónica recurrente tras angioplastia pulmonar con balón. #REC #AheadOfPrint Claudio Rivadulla Ignacio Fernández Herrero Nicolás Maneiro Fernando Sarnago Ceb maite velazquez martin 🔗 revespcardiol.org/es-hipertensio…

Happy to share our latest collaborative work: "Approach to Lung Transplantation in #PAH: A Delphi Consensus" just published online in Pulmonary Circulation Savale Laurent Pulmotension Société de Pneumologie de Langue Française (SPLF) InsermU999 HTaPFrance onlinelibrary.wiley.com/doi/10.1002/pu…

A key contribution on a major topic "Initial therapy in patients with #PAH and cardiovascular comorbidities" just published in ERS publications Thanks to Athénaïs Boucly Savale Laurent and the Pulmotension network Société de Pneumologie de Langue Française (SPLF) publications.ersnet.org/content/erj/65…

Tras #SAC25 nuestra actividad científica no para‼️ Nuevo #CardioSpaceSAC de un tema muy interesante: 📌”Claves Clínicas en Hipertensión arterial Pulmonar” 🗓️Martes 10 junio a las 20h (GMT+1) Coordina: Diego Segura-Rodríguez 📝Panelistas: María Lázaro Salvador PhD Rafael Bravo Marqués victorio cuenca

Progresión de la Forma de Onda de la ITV del TSVD. 🫀💥🫁 🟣Utilizando la señal Doppler espectral continuo (CW), se mide el tiempo de aceleración (TA) del TSVD. Un TA TSVD >105 ms se considera normal. 🟣El contorno del perfil de la Integral Velocidad-Tiempo (ITV) del Tracto de

Hoy en #CardioSpacesSAC Rafael Bravo Marqués nos hablará de la estratificación del riesgo en Hipertensión Arterial Pulmonar Conéctate a las 8pm aqui x.com/i/spaces/1YqKD…